Psychiatry · Indianapolis, IN
NPI
1801842422
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
9310 Waldemar Rd
Indianapolis, IN, 46268
Phone (317) 879-1303
Medicare paid, 2024
$53K
1,030 services
Medicare patients, 2024
294
Average age 72
Drug cost, 2024
$1.2M
9,283 prescriptions
Company payments, 2025
$642
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark R Ogle was code 99213 (office e&m - established), 930 times for 269 patients. In total Mark R Ogle billed 1,030 services in 8 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 930 | 269 | $51.30 | $48K |
| 99308 SNF E&M | Office | 29 | 16 | $48.00 | $1,392 |
| 90792 Psychotherapy - Nongroup | Office | 17 | 17 | $110.38 | $1,877 |
By year: 2022 $74K for 1,271 services; 2023 $65K for 1,108 services; 2024 $53K for 1,030 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark R Ogle prescribed most often to Medicare patients was Bupropion Xl (Bupropion Hcl), with 584 prescriptions and refills. In total Mark R Ogle wrote 9,283 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Bupropion Xl Bupropion Hcl | 584 | 1,506 | 124 | $16K |
| Buspirone Hcl Generic | 468 | 944 | 100 | $7,795 |
| Escitalopram Oxalate Generic | 410 | 797 | 78 | $4,864 |
| Olanzapine Generic | 392 | 624 | 67 | $22K |
| Clonazepam Generic | 382 | 462 | 60 | $3,163 |
| Trazodone Hcl Generic | 381 | 828 | 105 | $3,718 |
| Alprazolam Generic | 338 | 366 | 64 | $2,429 |
| Duloxetine Hcl Generic | 328 | 753 | 75 | $11K |
| Risperidone Generic | 326 | 464 | 46 | $4,454 |
| Aripiprazole Generic | 319 | 663 | 82 | $20K |
| Quetiapine Fumarate Generic | 311 | 653 | 58 | $8,951 |
| Mirtazapine Generic | 291 | 619 | 67 | $5,643 |
| Lorazepam Generic | 280 | 326 | 51 | $1,416 |
| Lamotrigine Generic | 249 | 565 | 59 | $3,403 |
| Divalproex Sodium Generic | 206 | 298 | 35 | $8,557 |
Brand drugs: 568 claims; generic drugs: 8,715 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark R Ogle $642 ($642 in general payments such as food, travel and fees) from 12 companies. The largest payer was Vanda Pharmaceuticals Inc. with $169.
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. VNDA | 10 | $169 |
| Abbvie Inc. ABBV | 5 | $102 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $75.98 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $59.25 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $52.91 |
| Axsome Therapeutics, Inc. AXSM | 3 | $51.48 |
| Lundbeck LLC | 2 | $33.05 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $29.88 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $19.39 |
| Almatica Pharma LLC | 1 | $19.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.